Trusted Press Release Distribution   Plans | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
Doug Bollard

Bookmark and Share
Potential $9.50 Buyout Rumor for Intellipharmaceutics
Potential $9.50 Buyout Rumor for Intellipharmaceutics

BriefingWire.com, 9/18/2016 - The rumor mill of mergers and acquisitions that surrounds the pharmaceutical industry has thrown up the names of Teva Canada Ltd. and Intellipharmaceutics, with the former reportedly poised to launch a takeover bid of the biotechnology firm based in Toronto, Ontario, Canada. The latest rumor serves to inspire that Teva is prepared to pay $503 million in stock to acquire Intellipharmaceutics. Teva denied that the two companies are discussing a takeover, but also declined to say whether any talks have been held in the past says our source.

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2024 Proserve Technology, Inc.